Share on StockTwits

Opko Health (NYSE:OPK) CEO Phillip Md Et Al Frost acquired 27,000 shares of Opko Health stock on the open market in a transaction dated Thursday, February 20th. The stock was purchased at an average price of $8.56 per share, for a total transaction of $231,120.00. Following the acquisition, the chief executive officer now directly owns 1,987,500 shares in the company, valued at approximately $17,013,000. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of Opko Health (NYSE:OPK) traded up 4.02% on Friday, hitting $9.0601. 2,474,254 shares of the company’s stock traded hands. Opko Health has a 52-week low of $6.14 and a 52-week high of $12.95. The stock has a 50-day moving average of $8.32 and a 200-day moving average of $9.16. The company’s market cap is $3.696 billion.

A number of research firms have recently commented on OPK. Analysts at Barrington Research raised their price target on shares of Opko Health to $11.00 in a research note on Friday, December 20th. Analysts at Jefferies Group reiterated a “buy” rating on shares of Opko Health in a research note on Wednesday, December 18th.

OPKO Health, Inc (NYSE:OPK), incorporated in October 1991, is a multi-national pharmaceutical and diagnostics company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.